Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2026)

Fulgent Genetics has reported Other Accumulated Expenses for 8 years, with the latest figure at $2.6 million in Q2 2026.

• Quarterly Other Accumulated Expenses fell 48.67% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.6 million (down 48.67% YoY) and the FY2025 annual result came in at $2.8 million, down 21.66% from the prior year.
• Other Accumulated Expenses grew to $2.6 million in Q2 2026 per FLGT's latest filing, from $2.5 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $13.6 million in Q3 2022 and troughed at $281000.0 in Q3 2023.
• A 5-year average of $3.8 million and a median of $3.7 million in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses plunged 97.94% in 2023, then jumped 1345.55% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $5.3 million in 2022, then dropped by 20.49% to $4.2 million in 2023, then decreased by 13.78% to $3.6 million in 2024, then decreased by 21.66% to $2.8 million in 2025, then declined by 9.31% to $2.6 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $2.6 million, $2.5 million, and $2.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.